Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status

BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer

Mingzhao Xing, William H. Westra, Ralph P. Tufano et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 994 citations · Full text

Medicine, Oncology, Metastasis +15

Predicting lung cancer by detecting aberrant promoter methylation in sputum.

William A. Palmisano, Kevin K. Divine, Geno Saccomanno et al. · PubMed · 2000 · 817 citations

Medicine, Molecular Biology, Oncology +17

BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism

Cosimo Durante, Efisio Puxeddu, Elisabetta Ferretti et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 396 citations · Full text

Medicine, Genetics, Oncology +15

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

Debyani Chakravarty, Elmer Santos, Mabel Ryder et al. · Journal of Clinical Investigation · 2011 · 387 citations

Medicine, Oncology, Pharmacology +17

The BRAFV600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer

Garcilaso Riesco‐Eizaguirre, Irene Rodrı́guez, Antonio De la Vieja et al. · Cancer Research · 2009 · 262 citations

Medicine, Cancer Biology, Oncology +17